Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moan, moan, panic, panic,,,"It has to be the '148 re-exam..."

everyone understands the constrained operational environment this company must exists within until the uncertanty is lifted.

If only that were so, and this was my point: why buy a stock where there is known uncertainty, then complain about the uncertainty.

There is however one certainty, licensing is ongoing despite the USPTO re-examinations.

Be well

Share
New Message
Please login to post a reply